Clinical characteristics of Dieulafoy's lesion in the small bowel diagnosed and treated by double-balloon endoscopy
- PMID: 37620810
- PMCID: PMC10464443
- DOI: 10.1186/s12876-023-02913-1
Clinical characteristics of Dieulafoy's lesion in the small bowel diagnosed and treated by double-balloon endoscopy
Abstract
Background: Obscure gastrointestinal bleeding refers to bleeding for which the source cannot be ascertained even through balloon-assisted endoscopy. In certain instances, Dieulafoy's lesion in the small bowel is presumed to be the underlying cause.
Aim: This retrospective study aimed to elucidate the clinical characteristics of Dieulafoy's lesion in the small bowel as diagnosed via double-balloon endoscopy while also exploring the feasibility of predicting bleeding from Dieulafoy's lesion prior to endoscopy in cases of obscure gastrointestinal bleeding.
Methods: A comprehensive analysis of our database was conducted, identifying 38 patients who received a diagnosis of Dieulafoy's lesion and subsequently underwent treatment via double-balloon endoscopy. The clinical background, diagnosis, and treatment details of patients with Dieulafoy's lesion were carefully examined.
Results: The median age of the 38 patients was 72 years, and 50% of the patients were male. A total of 26 (68%) patients exhibited a high comorbidity index. The upper jejunum and lower ileum were the most frequently reported locations for the occurrence of Dieulafoy's lesion in the small bowel. The detected Dieulafoy's lesions exhibited active bleeding (n = 33) and an exposed vessel with plaque on the surface (n = 5). Rebleeding after endoscopic treatment occurred in 8 patients (21%, median period: 7 days, range: 1-366 days). We conducted an analysis to determine the definitive nature of the initial double-balloon endoscopy diagnosis. Multivariate analysis revealed that hematochezia of ≥ 2 episodes constituted the independent factor associated with ≥ 2 double-balloon endoscopy diagnoses. Additionally, we explored factors associated with rebleeding following endoscopic treatment. Although the number of hemoclips utilized displayed a likely association, multivariate analysis did not identify any independent factor associated with rebleeding.
Conclusion: If a patient encounters multiple instances of hematochezia, promptly scheduling balloon-assisted endoscopy, equipped with optional instruments without delay is advised, after standard endoscopic evaluation with esophagogastroduodenoscopy and colonoscopy is unrevealing.
Keywords: Balloon-assisted endoscopy; Dieulafoy’s lesion; Obscure gastrointestinal bleeding; Rebleeding; Small bowel.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
Not applicable.
Figures
Similar articles
-
[Clinical aspects and endoscopic management of gastrointestinal bleeding from Dieulafoy's lesion].Rev Esp Enferm Dig. 2007 Sep;99(9):505-10. doi: 10.4321/s1130-01082007000900005. Rev Esp Enferm Dig. 2007. PMID: 18052645 Spanish.
-
Recurrent small-bowel bleeding from a Dieulafoy's lesion after combined endoscopic treatment.Rev Esp Enferm Dig. 2020 Apr;112(4):269-272. doi: 10.17235/reed.2020.6899/2020. Rev Esp Enferm Dig. 2020. PMID: 32193938
-
Outcomes of endoscopic treatment of gastroduodenal Dieulafoy's lesion with rubber band ligation and thermal/injection therapy.J Clin Gastroenterol. 2003 Apr;36(4):310-4. doi: 10.1097/00004836-200304000-00006. J Clin Gastroenterol. 2003. PMID: 12642736
-
Jejunal Dieulafoy's Lesion: A Systematic Review of Evaluation, Diagnosis, and Management.J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:2324709620987703. doi: 10.1177/2324709620987703. J Investig Med High Impact Case Rep. 2021. PMID: 33472441 Free PMC article.
-
Dieulafoy's lesion: an overview.Mymensingh Med J. 2014 Jan;23(1):186-94. Mymensingh Med J. 2014. PMID: 24584397 Review.
Cited by
-
Small Bowel Bleeding Due to Vascular Lesions: Pathogenesis and Management.Curr Gastroenterol Rep. 2025 Jun 7;27(1):37. doi: 10.1007/s11894-025-00989-1. Curr Gastroenterol Rep. 2025. PMID: 40481967 Free PMC article. Review.
-
Dieulafoy's Lesion: A Rare and Elusive Cause of Massive Upper Gastrointestinal Bleeding Managed With Endoscopic Therapy.Cureus. 2025 Jan 9;17(1):e77206. doi: 10.7759/cureus.77206. eCollection 2025 Jan. Cureus. 2025. PMID: 39925567 Free PMC article.
-
Forrest-type IIb increases the risk of rebleeding after endoscopic treatment in patients with Dieulafoy's lesion of the upper gastrointestinal tract.Ann Med. 2025 Dec;57(1):2478645. doi: 10.1080/07853890.2025.2478645. Epub 2025 Mar 13. Ann Med. 2025. PMID: 40083167 Free PMC article.
-
Complex Presentation of a Dieulafoy Lesion in a Geriatric Patient with Multiple Comorbidities.Cureus. 2023 Oct 30;15(10):e47985. doi: 10.7759/cureus.47985. eCollection 2023 Oct. Cureus. 2023. PMID: 38034218 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources